ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2024
Novel Dynamic Organ Storage System Enhances Liver Graft Function in a Porcine Donation After Circulatory Death Model.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shishido Yutaka, Tracy Kaitlyn M, Petrovic Mark, Adesanya TiOluwanimi, Fortier Avery K, Raietparvar Kimya, Glomp Gabriella A, Simonds Elizabeth, Harris Timothy R, Simon Victoria, Tucker William D, Petree Brandon, Cortelli Michael, Cardwell Nancy L, Crannell Christian, Liang Jiancong, Murphy Alexandria C, Fields Blanche L, McReynolds Melanie, Demarest Caitlin T, Ukita Rei, Rizzari Michael, Montenovo Martin, Magliocca Joseph F, Karp Seth J, Rauf M Ameen, Shah Ashish S, Bacchetta Matthew
Аннотация
Donation after circulatory death (DCD) livers face increased risks of critical complications when preserved with static cold storage (SCS). Although machine perfusion (MP) may mitigate these risks, its cost and logistical complexity limit widespread application. We developed the Dynamic Organ Storage System (DOSS), which delivers oxygenated perfusate at 10°C with minimal electrical power requirement and allows real-time effluent sampling in a portable cooler. In a porcine DCD model, livers were preserved using DOSS or SCS for 10 hours and evaluated with 4 hours of normothermic MP, with n = 5 per group. After 4 hours of normothermic MP, the DOSS group demonstrated significantly lower perfusate lactate ( p = 0.023), increased perfusate fibrinogen ( p = 0.005), higher oxygen consumption ( p = 0.018), greater bile production ( p = 0.013), higher bile bicarbonate levels ( p = 0.035) and bile/perfusate sodium ratio ( p = 0.002), and lower hepatic arterial resistance after phenylephrine administration ( p = 0.018). Histological analysis showed lower apoptotic markers in DOSS-preserved livers, with fewer cleaved caspase-3 ( p = 0.039) and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL; p = 0.009) positive cells. These findings suggest that DOSS can enhance DCD allograft function during transport, offering potential clinical benefits and contributing to the expansion of the donor pool.